CGTX

← Markets

CGTXCognition Therapeutics, Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Thu, Aug 6
6:10 PMYahooCognition Therapeutics, Inc. (CGTX) Reports Q2 Loss, Lags Revenue Estimates
3:15 PMYahooCognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update
Mon, Jul 13
6:30 AMYahooCognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit
Wed, Jun 24
10:47 AMstocktwits.comCognition Therapeutics Gets Positive FDA Feedback Over Phase 3 Study Of DLB Psychosis – But CGTX Stock Just Crashed 33%
7:46 AMinvestorshub.advfn.comCognition Therapeutics Advances After FDA Supports Key Elements of Pivotal Trial Plan (CGTX)
6:30 AMYahooCognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
Tue, Jun 16
6:30 AMYahooCognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT1812) Through 2045
Tue, Jun 2
8:56 AMYahooIs Cognition Therapeutics, Inc. (CGTX) Moving Closer to a Registrational Trial in Dementia With Lewy Bodies?
Mon, Jun 1
6:30 AMYahooCognition Therapeutics Participating in Upcoming Investor Conferences
Thu, May 21
6:30 AMYahooCognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis
Thu, May 14
6:30 AMYahooCognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
Thu, May 7
3:15 PMYahooCognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update